These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16581270)

  • 21. QT interval correction for drug-induced changes in body temperature during integrated cardiovascular safety assessment in regulatory toxicology studies in dogs: A case study.
    El Amrani AI; El Amrani-Callens F; Loriot S; Singh P; Forster R
    J Pharmacol Toxicol Methods; 2016; 81():136-43. PubMed ID: 27095299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
    Kågström J; Sjögren EL; Ericson AC
    J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A one-step approach to the analysis of the QT interval in conscious telemetrized dogs.
    Chiang AY; Holdsworth DL; Leishman DJ
    J Pharmacol Toxicol Methods; 2006; 54(2):183-8. PubMed ID: 16567113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.
    Chen X; Cass JD; Bradley JA; Dahm CM; Sun Z; Kadyszewski E; Engwall MJ; Zhou J
    Br J Pharmacol; 2005 Nov; 146(6):792-9. PubMed ID: 16158069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs.
    Rajput SK; Singh JN; Sharma SS
    Pharmacol Rep; 2010; 62(4):683-8. PubMed ID: 20885008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
    Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
    J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation.
    Miyazaki H; Watanabe H; Kitayama T; Nishida M; Nishi Y; Sekiya K; Suganami H; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):523-9. PubMed ID: 16493192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QT PRODACT: usability of miniature pigs in safety pharmacology studies: assessment for drug-induced QT interval prolongation.
    Kano M; Toyoshi T; Iwasaki S; Kato M; Shimizu M; Ota T
    J Pharmacol Sci; 2005; 99(5):501-11. PubMed ID: 16493190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium.
    Boulay E; Abernathy MM; Chui R; Friedrichs GS; Gendron-Parra N; Greiter-Wilke A; Guillon JM; Koerner JE; Menard A; Steidl-Nichols J; Pierson J; Pugsley MK; Rossman EI; Strauss D; Troncy E; Valentin JP; Wisialowski T; Authier S
    Int J Toxicol; 2019; 38(1):23-32. PubMed ID: 30567462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.
    Lande G; Maison-Blanche P; Fayn J; Ghadanfar M; Coumel P; Funck-Brentano C
    Clin Pharmacol Ther; 1998 Sep; 64(3):312-21. PubMed ID: 9757155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog.
    Taylor GL; Patel B; Sullivan AT
    J Pharmacol Toxicol Methods; 2007; 56(2):212-7. PubMed ID: 17582788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc).
    Chiang AY; Bass AS; Cooper MM; Engwall MJ; Menton RG; Thomas K
    J Pharmacol Toxicol Methods; 2007; 56(2):95-102. PubMed ID: 17588780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
    Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research.
    Van Deuren B; Van Ammel K; Somers Y; Cools F; Straetemans R; van der Linde HJ; Gallacher DJ
    J Pharmacol Toxicol Methods; 2009; 60(1):11-23. PubMed ID: 19422925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
    Ando K; Hombo T; Kanno A; Ikeda H; Imaizumi M; Shimizu N; Sakamoto K; Kitani S; Yamamoto Y; Hizume S; Nakai K; Kitayama T; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):487-500. PubMed ID: 16493189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach to correct the QT interval for changes in heart rate using a nonparametric regression model in beagle dogs.
    Watanabe H; Miyazaki H
    J Pharmacol Toxicol Methods; 2006; 53(3):234-41. PubMed ID: 16297641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model.
    Lu HR; Remeysen P; Somers K; Saels A; De Clerck F
    J Cardiovasc Electrophysiol; 2001 May; 12(5):538-45. PubMed ID: 11386514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.
    Dubois VF; Casarotto E; Danhof M; Della Pasqua O
    Br J Pharmacol; 2016 Oct; 173(19):2819-32. PubMed ID: 27427789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.